Open Access#1
An analysis of the intervention of Hong Kong government in the housingmarket
published_or_final_version ; Real Estate and Construction ; Master ; Master of Science in Construction Project Management
Suchergebnisse
Filter
2 Ergebnisse
Sortierung:
BASE
Open Access#22021
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Coggins, Si'Ana A; Laing, Eric D; Olsen, Cara H; Goguet, Emilie; Moser, Matthew; Jackson-Thompson, Belinda M; Samuels, Emily C; Pollett, Simon D
Coggins, Si'Ana A; Laing, Eric D; Olsen, Cara H; Goguet, Emilie; Moser, Matthew; Jackson-Thompson, Belinda M; Samuels, Emily C; Pollett, Simon D; Tribble, David R; Davies, Julian; Illinik, Luca; Hollis-Perry, Monique; Maiolatesi, Santina E; Duplessis, Christopher A; Ramsey, Kathleen F; Reyes, Anatalio E; Alcorta, Yolanda; Wong, Mimi A; Wang, Gregory; Ortega, Orlando; Parmelee, Edward; Lindrose, Alyssa R; Snow, Andrew L; Malloy, Allison M.W; Letizia, Andrew G; Powers, John H; Burgess, Timothy H; Broder, Christopher C; Mitre, Edward
BACKGROUND: mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear. OBJECTIVE: To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels. DESIGN: Single center, prospective, observational cohort study. SETTING: Participants worked at Walter Reed National Military Medical Center and were seen monthly at the Naval Medical Research Center Clinical Trials Center. PARTICIPANTS: Generally healthy adults that were not severely immunocompromised, had no history of COVID-19, and were seronegative for SARS-CoV-2 spike protein prior to vaccination. MEASURES: Severity of vaccine-associated symptoms was obtained through participant completed questionnaires. Testing for IgG antibodies against SARS-CoV-2 spike protein and receptor binding domain was conducted using microsphere-based multiplex immunoassays. RESULTS: 206 participants were evaluated (69.4% female, median age 41.5 years old). We found no correlation between vaccine-associated symptom severity scores and vaccine-induced antibody titers one month after vaccination. We also observed that 1) post-vaccination symptoms were inversely correlated with age and weight and more common in women, 2) systemic symptoms were more frequent after the second vaccination, 3) high symptom scores after first vaccination were predictive of high symptom scores after second vaccination, and 4) older age was associated with lower titers. LIMITATIONS: Study only observes antibody responses and consists of healthy participants. CONCLUSIONS: Lack of post-vaccination symptoms following receipt of the BNT162b2 vaccine does not equate to lack of vaccine-induced antibodies one month after vaccination. This study also suggests that it may be possible to design future mRNA vaccines that confer robust antibody responses with lower frequencies of vaccine-associated ...
BASE